Blockchain Registration Transaction Record

Kairos Pharma's KROS101 Shows Promise in Cancer Immunotherapy at ASCO 2025

Kairos Pharma presents KROS101 data at ASCO 2025, showcasing potential in cancer immunotherapy. Discover how this could change treatment paradigms.

Kairos Pharma's KROS101 Shows Promise in Cancer Immunotherapy at ASCO 2025

This news is significant as it highlights a potential breakthrough in cancer treatment, offering hope for patients with resistant forms of cancer. KROS101's dual mechanism could pave the way for more effective immunotherapies, addressing a critical need in oncology. The advancement of ENV105 also represents a promising avenue for overcoming drug resistance, a major challenge in cancer therapy today.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x871b7b1a26a26cabe851842ded75b2fdb04a6c5ad4bf9f69a66844b085c71899
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintcoolrrtx-3e0989dea20ce949b7e9db098db0138b